Indeed, mutations of the TET2 gene frequently occur in myeloid malignancies, including acute myeloid leukemia (AML) and chronic myeloid leukemia (CMML), among others, and are associated with a worse prognosis (4). The gene discussed is TET2; the disease is chronic myelomonocytic leukemia.